melenoma - Nursing Case Study
Pathophysiology
• Primary mechanism: Melanoma originates from the malignant transformation of melanocytes, primarily due to DNA damage from UV radiation. This damage leads to mutations in critical genes like BRAF and NRAS, which regulate cell growth and survival, resulting in uncontrolled cellular proliferation.
• Secondary mechanism: Immune evasion plays a crucial role, as melanoma cells exploit immune checkpoint pathways, such as PD-1/PD-L1, to inhibit T-cell mediated immune responses, allowing tumor progression and metastasis.
• Key complication: Metastatic spread is a severe concern, as melanoma cells can disseminate via lymphatic and hematogenous routes, leading to secondary tumors in vital organs such as the brain, lungs, and liver, significantly impacting morbidity and mortality.
Patient Profile
Demographics:
62-year-old male, retired construction worker
History:
• Key past medical history: Stage IV melanoma, hypertension, type 2 diabetes, history of smoking (30 pack-years)
• Current medications: Pembrolizumab, Metformin, Lisinopril, Atorvastatin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe abdominal pain and difficulty breathing
• Key symptoms: Weight loss, fatigue, persistent cough, night sweats, jaundice
• Vital signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 85% on room air
Section 1
New Diagnostic Results:
Following the initial assessment, the medical team ordered a series of diagnostic tests to evaluate the extent of the metastatic melanoma and its complications. A CT scan of the chest and abdomen revealed multiple metastatic lesions in the liver and significant pleural effusion in the right lung, contributing to his respiratory distress. The liver lesions were consistent with metastatic melanoma, characterized by irregular margins and a hypervascular pattern. Additionally, a bronchoscopy was performed, revealing endobronchial involvement, which partially explained the persistent cough and compromised oxygen saturation. Laboratory tests showed an elevated bilirubin level at 4.5 mg/dL, indicative of hepatic dysfunction, and a lactate level of 5.2 mmol/L, suggestive of tissue hypoxia and possible sepsis.
Further complicating the clinical picture, his complete blood count revealed leukocytosis with a white blood cell count of 15,000/µL, and a markedly elevated C-reactive protein level of 150 mg/L, pointing towards an inflammatory or infectious process. The blood cultures returned positive for Pseudomonas aeruginosa, indicating a secondary bacterial infection likely contributing to the patient's fever and systemic inflammatory response. The presence of jaundice and elevated liver enzymes (AST 150 U/L, ALT 135 U/L) raised concerns about liver failure, compounded by the metastatic burden. These results necessitate immediate attention to manage the patient's hemodynamic instability, respiratory distress, and potential sepsis, requiring advanced critical thinking to prioritize and implement effective interventions.
Section 2
Change in Patient Status:
As the medical team initiated interventions to stabilize the patient, his clinical status began to evolve rapidly. Despite aggressive intravenous antibiotic therapy aimed at eradicating the Pseudomonas aeruginosa infection, the patient exhibited signs of worsening sepsis. His temperature spiked to 39.8°C (103.6°F), and he became increasingly tachycardic, with a heart rate climbing to 125 beats per minute. Blood pressure readings fluctuated, with a concerning drop to 85/50 mmHg, indicating potential septic shock. The respiratory distress intensified, as evidenced by a respiratory rate of 32 breaths per minute and an oxygen saturation plummeting to 85% on high-flow oxygen.
Concurrently, the patient's neurological status deteriorated. He became lethargic and disoriented, with a Glasgow Coma Scale score dropping to 10. This change raised alarms about possible hepatic encephalopathy, given his elevated bilirubin levels and compromised liver function. The medical team was compelled to reassess the treatment plan, with considerations for escalating care to the Intensive Care Unit for closer monitoring and potential interventions such as vasopressor support and advanced respiratory management. These developments required the team to exercise nuanced clinical judgment, balancing the need to address the immediate life-threatening conditions while not losing sight of the underlying metastatic melanoma and its systemic complications.
Section 3
As the patient was transferred to the Intensive Care Unit, the medical team prioritized a comprehensive reassessment to guide further interventions. The initial laboratory results from the ICU admission painted a grim picture. The patient's white blood cell count had surged to 22,000/mm³, indicative of an overwhelming systemic infection. Serum lactate levels were critically elevated at 5.5 mmol/L, underscoring the severity of the septic shock. Liver function tests revealed a dramatic rise in transaminases, with AST and ALT levels both exceeding 500 U/L, suggesting acute hepatic injury possibly exacerbated by the systemic inflammatory response and the underlying metastatic burden. Furthermore, an emergent CT scan of the abdomen and pelvis revealed widespread metastatic lesions in the liver, with significant periportal edema, which could be contributing to the hepatic dysfunction and altered mental status.
Despite the administration of broad-spectrum antibiotics and fluid resuscitation, the patient's hemodynamic status remained precarious. The decision was made to initiate vasopressor support with norepinephrine to maintain mean arterial pressure above 65 mmHg. Simultaneously, the team commenced continuous renal replacement therapy due to acute kidney injury, as evidenced by a creatinine spike to 3.2 mg/dL and oliguria. The patient's respiratory distress prompted the initiation of mechanical ventilation to optimize oxygenation and reduce the metabolic demand on the already compromised systems.
As the team grappled with managing these acute complications, a new challenge surfaced. The patient's coagulation profile indicated a developing disseminated intravascular coagulation (DIC) syndrome, with a platelet count plummeting to 40,000/mm³, elevated D-dimer levels, and prolonged PT and aPTT times. This complication further complicated the clinical picture, requiring careful balancing of anticoagulation to mitigate the risk of thrombosis against the potential for catastrophic bleeding. The medical team was faced with critical decision points, necessitating advanced clinical reasoning to prioritize interventions that would stabilize the patient while addressing the multifaceted challenges posed by the intersecting pathologies of infection, organ dysfunction, and malignancy.
Section 4
As the medical team navigated the complexity of the patient's condition, new diagnostic results revealed further deterioration. A repeated CT scan of the chest showed evidence of bilateral pleural effusions and atelectasis, contributing to the patient's persistent hypoxia despite mechanical ventilation. Concurrently, a transthoracic echocardiogram was performed due to the patient's refractory hypotension and revealed reduced left ventricular ejection fraction at 35%, suggestive of sepsis-induced cardiomyopathy. The echocardiogram also identified a small pericardial effusion without signs of tamponade, adding another layer to the cardiac complications.
In the laboratory, the patient's metabolic panel indicated worsening acidosis with a pH of 7.2 and bicarbonate level of 15 mmol/L, suggesting inadequate perfusion and persistent lactic acidosis. Arterial blood gases confirmed a PaO2 of 60 mmHg and a PaCO2 of 50 mmHg, highlighting the challenges in achieving adequate gas exchange. Meanwhile, the patient's coagulation parameters continued to deteriorate, with fibrinogen levels dropping below 150 mg/dL, exacerbating the risk of spontaneous bleeding. Given the critical nature of the findings, the medical team deliberated on the initiation of inotropic support to improve cardiac output and considered the cautious use of fresh frozen plasma and cryoprecipitate to stabilize the coagulation cascade.
The patient's condition prompted the involvement of a multidisciplinary team to reassess the treatment strategy. Oncology specialists were consulted to discuss the feasibility of initiating targeted therapy to address the metastatic melanoma, while palliative care services were engaged to support the patient's family in understanding the prognosis and potential outcomes. The team's focus remained on balancing aggressive interventions with the patient's overall quality of life and aligning the treatment goals with the patient's values and wishes. This collaborative approach was crucial as the team sought to navigate the intersecting challenges of multi-organ failure, infection, and cancer progression, ultimately driving the next steps in the patient's intensive care management.
Section 5
As the medical team continued to monitor the patient, a sudden change in the patient's status further complicated the clinical picture. The patient's blood pressure plummeted to 70/45 mmHg, despite aggressive fluid resuscitation and the initiation of inotropic support with norepinephrine. Heart rate escalated to 125 beats per minute, and the patient developed a new onset of atrial fibrillation, adding another layer of complexity to the already fragile cardiovascular status. The electrocardiogram confirmed the arrhythmia, prompting the team to initiate amiodarone while carefully balancing the risk of further hemodynamic instability.
In parallel, the patient's respiratory status worsened, with increasing oxygen requirements reaching an FiO2 of 0.80 on the ventilator to maintain oxygen saturation above 88%. A repeat chest x-ray revealed progression of the bilateral pleural effusions and worsening atelectasis, despite ongoing chest physiotherapy and diuretics. The intensivist considered the potential need for thoracentesis to relieve the effusions, but the patient's coagulopathy posed a significant bleeding risk. Meanwhile, the renal function deteriorated with creatinine levels rising to 4.0 mg/dL, indicative of acute kidney injury likely secondary to the ongoing sepsis and hypotension, necessitating discussions about renal replacement therapy.
Simultaneously, the oncology team evaluated the possibility of introducing a BRAF/MEK inhibitor given the patient's melanoma mutation profile. However, the critical nature of the patient's condition and the need for immediate stabilization took precedence. The palliative care team continued to work closely with the family, providing support and discussing the goals of care in light of the new developments. The multidisciplinary team faced challenging decisions, weighing the benefits and burdens of potential interventions while striving to honor the patient's values and ensuring a dignified approach to care amid the cascading complications.